Overweight and obesity prevalence in children based on 6- or 12-month IOTF cut-points: does interval size matter?

P J Kremer1, A C Bell, A M Sanigorski

  • 1School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia. peter.kremer@deakin.edu.au

Insights

Using different age intervals for International Obesity Taskforce (IOTF) body mass index (BMI) cut-points introduces bias in childhood overweight and obesity prevalence estimates. This bias varies by age, underestimating prevalence in older children.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • The International Obesity Taskforce (IOTF) provides age- and gender-specific body mass index (BMI) cut-points for defining childhood overweight and obesity.
  • These cut-points are available in 6- and 12-month age intervals.
  • Nonlinear BMI-for-age curves can introduce bias when using wider age intervals.

Purpose of the Study:

  • To quantify the bias in overweight and obesity prevalence estimates introduced by using 12-month versus 6-month age intervals for IOTF cut-points.
  • To assess the age-dependency of this bias in Australian children.

Main Methods:

  • Analysis of body mass index (BMI) data from 2178 Australian children aged 4-12 years.
  • Comparison of prevalence estimates for overweight and obesity using 6-month versus 12-month age intervals based on IOTF criteria.
  • Assessment of bias across different age groups.

Main Results:

  • Using 12-month intervals underestimated overall overweight and obesity prevalence by 1.4% compared to 6-month intervals.
  • The bias was age-dependent: overestimation in 4-year-olds and underestimation (up to 2.6%) in older children.
  • Overweight prevalence was more affected by the interval difference than obesity prevalence.

Conclusions:

  • The choice of age interval (6- vs. 12-month) for IOTF BMI cut-points introduces a small but systematic bias in childhood overweight and obesity prevalence estimates.
  • This bias is age-dependent, impacting prevalence figures differently across pediatric age groups.
  • Accurate prevalence estimation requires careful consideration of age interval selection in applying IOTF guidelines.